STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
scientific article published on June 11, 2015
Author/s
author:
Juliann Chmielecki,
Charles F. Levenback
Wikidata